🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06712992
Active, not recruiting Not applicable

Electromyographic Response to TsDcs in CNSLBP

NCT06712992 · tracked via the Priya Life Science Egypt tracker
Sponsor
German International University
Phase
Not applicable
Started
2024-05-16
Last updated
2025-03-12

Condition(s) studied

Low Back Pain

Investigational drug(s) / intervention(s)

Trans-spinal Direct Current StimulationConventional ExercisesSHAM Trans-spinal Direct current stimulation

Trans-spinal Direct Current Stimulation: Physiomed- IONOSON-Expert, Germany will be used to deliver SHAM direct current, The Physiomed- IONOSON-Expert, Germany is Two-channel electrotherapy including 21 currents, including direct current. The tsDCS electrodes will be rectangular pieces of saline-soaked synthetic sponge (7 × 8 cm, 56 cm2), to minimize chemical reactions at the electrode-skin interface. The anode will be placed over the spinous process of the eighth thoracic vertebra (T8) and the cathode will be placed on the second lumbar vertebra (L2) according to a modeling study which demonstrated that this configuration had a relevant impact on the distribution of the induced electric field (EF) in the lumbosacral spinal cord for the efficacy of tsDCS.

Conventional Exercises: 1. Isometric exercises of spine * Hollowing in abdominals. * Isometric for back extensors. 2. Bridging exercises. 3. Graded active flexion exercises of spine 4. Graded active extension exercises of spine

SHAM Trans-spinal Direct current stimulation: For a sham tsDCS, the current will be ramped up for 30 seconds turned on for 5 s and then turned off in a ramp shaped fashion, thus inducing skin sensations indistinguishable from anodal tsDCS. This method was shown to achieve a good level of blinding among sessions. These parameters for sham stimulation were chosen based on previous reports that the perceived sensations on the skin, such as tingling, fade usually out in the first 30 s of TsDcs .

Study summary

The purpose of this randomized, double-blinded, sham-controlled study is to investigate the efficacy of trans-spinal direct current stimulation on pain level, quality of life, and electromyographic nociceptive flexion reflex in patients with non-specific chronic low back pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Individuals of both sexes. * Age 18-60 years old. * Chronic non-specific low back pain according to the most recent guidelines for the diagnosis and management of NSLPB come from the American College of Physicians and was published in 2017. According to these guidelines, the diagnosis of chronic NSLBP should be made based on the following criteria: * Chronic low back pain, defined as pain lasting for more than 12 weeks. * No specific identifiable cause of pain(e.g. infection, malignancy, fracture, inflammatory disorder). * No radicular symptoms(e.g. pain radiating down the leg). * No significant neurological deficits or findings on physical examination(e.g. loss of reflexes or muscle strength). Exclusion Criteria: * Previous fractures and/or surgery in the vertebral spine. * Neuropathic pain extending along the lower limb due to nerve root compression. * History of spine trauma or fracture. * Implanted pacemakers. * Pregnancy. * Malignancy. * Systemic musculoskeletal diseases. * Epilepsy. * History of psychiatric disorders. * Obesity

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Outpatient clinic of faculty of physical therapy, Ahram Canadian University Sixth of October Giza Governorate
Outpatient clinical of faculty of physical therapy, Ahram Canadian University Sixth of October Giza Governorate

More German International University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06712992 on ClinicalTrials.gov ↗ ← All trials in Egypt